News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Common Baldness Drug Could Reduce Prostate Cancer Risk, University of Texas Health Science Center Study


8/16/2013 7:19:42 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

A drug used to treat enlarged prostate and male pattern baldness also reduces a man's risk of prostate cancer by nearly a third, according to a large new study. The findings on nearly 19,000 men also overturn earlier concerns that treatment with finasteride -- the agent in the prostate drug Proscar and the hair-loss drug Propecia -- might promote the development of more virulent prostate cancers in men who contract the disease, researchers said.

Hey, check out all the research scientist jobs. Post your resume today!



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES